Related Experiment Video
Updated: Nov 8, 2025

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Cardiovascular Manifestations in Inflammatory Bowel Disease: A Systematic Review of the Pathogenesis and Management
Ravi S Patel1, Sai Rohit Reddy1, Adiona Llukmani1
1Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Insights
Pericarditis in inflammatory bowel disease (IBD) is often a drug complication, not an IBD manifestation. Management involves stopping offending medications or using corticosteroids.
Area of Science:
- Gastroenterology
- Cardiology
- Immunology
Background:
- Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn's disease, is a chronic gastrointestinal disorder.
- Pericarditis, inflammation of the heart's outer lining, is a rare but serious complication associated with IBD.
- The exact cause of pericarditis in IBD patients remains debated: extraintestinal manifestation or drug-induced.
Purpose of the Study:
- To elucidate the pathogenesis of pericarditis in IBD patients.
- To determine if pericarditis is an extraintestinal manifestation or a drug-induced complication.
- To outline the management strategies for pericarditis in IBD, including the role of biologics.
Main Methods:
- Systematic electronic search for relevant reports on pericarditis in IBD.
- Quality assessment of identified articles based on predefined inclusion criteria.
- Inclusion of full-text articles published in English from inception to November 2020.
Main Results:
- The majority of evidence suggests pericarditis in IBD is a complication of 5-aminosalicylic acid derivatives (e.g., sulfasalazine, mesalamine).
- Mechanisms include IgE-mediated reactions, direct cardiac toxicity, cell-mediated hypersensitivity, and humoral antibody responses.
- Pericarditis is rarely considered a direct extraintestinal manifestation of IBD itself.
Conclusions:
- Pericarditis in IBD is predominantly linked to adverse drug reactions rather than being a direct disease manifestation.
- Drug cessation or corticosteroid therapy are effective first-line treatments for drug-induced pericarditis in IBD.
- Further research may clarify the role of biologics in preventing or managing pericarditis in this patient population.
Abstract:
Inflammatory bowel disease (IBD) is a chronic condition of the bowel that can be further categorized into ulcerative colitis and Crohn's disease. Rarely, this condition can be associated with pericarditis, which can be an extraintestinal manifestation of the disease or drug-induced. This review aims to determine the pathogenesis and management of pericarditis in IBD. In this review, the goal is to elucidate the pathogenesis of pericarditis in IBD and determine if pericarditis is an extraintestinal manifestation of IBD or a complication of current drug therapy used to manage IBD. Additionally, this review intends to explain the first-line management of pericarditis in IBD and explore the role of biologicals in attenuating pericarditis. An electronic search was conducted to identify relevant reports of pericarditis in IBD, and a quality assessment was conducted to identify high-quality articles according to the inclusion criteria. Full-text articles from inception to November 2020 were included, while non-English articles, gray literature, and animal studies were excluded. The majority of studies suggest that pericarditis arises as a complication of drug therapy by 5-aminosalicylic acid derivatives such as sulfasalazine, mesalamine, and balsalazide, and it occurs due to IgE-mediated allergic reactions, direct cardiac toxicity, cell-mediated hypersensitivity reactions, and humoral antibody response to therapy. Drug cessation or the initiation of a corticosteroid regimen seems to be the most effective means of managing pericarditis in IBD due to drug therapy or an extraintestinal manifestation.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Pericarditis I: Introduction
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management
Pericarditis II: Clinical Features and Diagnostic Tests

